Michael Egloff
Michael Egloff publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Lipoproteins and Cardiovascular Health.
- World rank
- #2,310,607 of 7,710,434 ranked researchers
- Rank in Switzerland
- #35,899 of 80,918
- Works
- 26
- Citations
- 1.2k
- Citations per work
- 46.2
What does Michael Egloff research?
Michael Egloff's work is mostly in Medicine (75%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2179.4%
- Medicine2075.3%
- Health Professions14.1%
- Everything else520.6%
- 1Cardiology and Cardiovascular Medicine22% of their works
- 2Internal Medicine19% of their works
- 3Surgery15% of their works
- 4Endocrinology, Diabetes and Metabolism12% of their works
- 5Epidemiology7% of their works
- 6General Health Professions4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Lipoproteins and Cardiovascular Health
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Heart Failure Treatment and Management
- Cardiac Health and Mental Health
- Antiplatelet Therapy and Cardiovascular Diseases
Which keywords describe Michael Egloff's research?
The keywords of their largest research topics: Diagnosis, Antithrombotic Therapy, Treatment, Pulmonary Embolism, Venous Thromboembolism, Guidelines, Anticoagulant Therapy and Atrial Fibrillation.
- Heart Failure
- Clopidogrel
- B-Type Natriuretic Peptide
- Thrombosis
- Protease-Activated Receptors
- Statins
- Atrial Fibrillation
- Guidelines
- Pulmonary Embolism
- Antithrombotic Therapy
- Diagnosis
- Treatment
- Venous Thromboembolism
- Anticoagulant Therapy
- Cholesterol-lowering
- Heparin-Induced Thrombocytopenia
- Thrombin
- Aspirin
- Cardiac Rehabilitation
- Depression
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Diagnosis193 topics
- Antithrombotic Therapy172 topics
- Treatment162 topics
- Pulmonary Embolism141 topic
- Venous Thromboembolism141 topic
- Guidelines122 topics
- Anticoagulant Therapy101 topic
- Atrial Fibrillation101 topic
- Cholesterol-lowering41 topic
- Statins41 topic
- Heparin-Induced Thrombocytopenia31 topic
- Protease-Activated Receptors31 topic
- Thrombin31 topic
- Thrombosis31 topic
- Aspirin21 topic
- B-Type Natriuretic Peptide21 topic
- Cardiac Rehabilitation21 topic
- Clopidogrel21 topic
- Depression21 topic
- Heart Failure21 topic
Where does Michael Egloff work?
Michael Egloff's main affiliation in the publication record is Kantonsspital Baden, Switzerland.
How many publications and citations does Michael Egloff have?
OpenAlex counts 26 works and 1,201 citations for Michael Egloff, an h-index of 14, ranking #2,310,607 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Egloff. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.